Team says a single molecule acting on GLP‑1, GIP, glucagon and PYY receptors produced larger weight‑loss effects in animals and may reduce common side effects of current injectable obesity drugs — but human testing has not begun.
Susan B. Anthony Pro‑Life America and allied groups press for Hyde-specific safeguards as debate intensifies over ACA payments and past regulatory changes
Physicians caution that self-injection, counterfeit products and lack of FDA oversight can cause facial paralysis, infection and rare life‑threatening complications
Irons opens up about her grief and suicidal thoughts while fronting a new Suicide Prevention Scotland podcast aimed at sparking national conversation
New York Post testers retested more than two dozen services and name EveryPlate the best overall while highlighting options for families, special diets and single-serve needs.
Post-mortem found exertional heat stroke caused cardiac arrest after swimmer collapsed in Swansea 70.3 triathlon amid a heatwave
A 21-year-old college student says repeated inconclusive tests, a denied PET scan and months of delays preceded a June 2025 Hodgkin lymphoma diagnosis and large diagnostic bills.
Child hospitalized and recovering after bite at New Beginnings Child Enrichment Center in Stony Point; police say no 911 call was made
A single engineered drug combines GLP‑1, GIP, glucagon and peptide YY signaling in lab studies; experts call for animal and human trials to assess safety and effectiveness